Medical Articles

Stem cells (SCs) hold great promise in cell therapy, tissue engineering, and regenerative medicine as well as pharmaceutical and biotechnological applications.

They have the ability to self-renew and the ability to differentiate into specialized cell types depending on the source of isolation. However, the use of SCs for clinical applications requires high quality and quantity of cells.

Glioblastoma is the most common and devastating primary brain tumor and the standard of care treatment includes maximal surgical resection followed by radiation and chemotherapy.

Retinal damage caused by ischemia, infection, or physical injury results in the degeneration or death of photoreceptor cells, as well as severe vision loss. No effective neuroprotective drugs are available in the clinic to restore damaged cells. Our research group has shown that intravenous transplantation of MSCs was effective in alleviating photoreceptor damage.

Idiopathic macular hole is a common ocular disease, causing severe visual impairment or blindness. The primary treatment is pars plana vitrectomy, and visual recovery depends on the status of hole closure and the function of photoreceptor cells in the macular area.